Abstract
In 48 new diagnosed epileptic patients, affected by partial simple or complex seizures with or without secondary generalization, GVG was administered as unique drug at a mean dose of 29 mg/kg/day. Minimum follow-up was 3 months, maximum 12 months. In about 80% of the patients a disappearance or a reduction ≥50% of the seizure frequency was obtained, without significant differences between cryptogenic and symptomatic etiology, thoughout the whole period of observation. Side effects, mainly body weight increment, were usually mild and transitory.
Translated title of the contribution | Vigabatrin monotherapy in partial epilepsy: Preliminary results of a open collaborative study |
---|---|
Original language | Italian |
Pages (from-to) | 81-82 |
Number of pages | 2 |
Journal | Bollettino - Lega Italiana contro l'Epilessia |
Issue number | 86-87 |
Publication status | Published - 1994 |
ASJC Scopus subject areas
- Clinical Neurology